{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:25:28Z","timestamp":1786980328856,"version":"build-2736575974"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2011,11,3]],"date-time":"2011-11-03T00:00:00Z","timestamp":1320278400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Gastroenterol"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1007\/s00535-011-0490-y","type":"journal-article","created":{"date-parts":[[2011,11,2]],"date-time":"2011-11-02T11:32:19Z","timestamp":1320233539000},"page":"21-28","source":"Crossref","is-referenced-by-count":64,"title":["Current status of primary malignant melanoma of the esophagus: clinical features, pathology, management and prognosis"],"prefix":"10.1007","volume":"47","author":[{"given":"Yoshimi","family":"Iwanuma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natsumi","family":"Tomita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takayuki","family":"Amano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuyumi","family":"Isayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiko","family":"Tsurumaru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuo","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiaki","family":"Kajiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,11,3]]},"reference":[{"key":"490_CR1","first-page":"343","volume":"5","author":"EH Baur","year":"1906","unstructured":"Baur EH. Ein Fall von Primaerem Melanoma de Oesophagus. Arb Geb Pathol Anat Inst Tuebingen. 1906;5:343\u201354.","journal-title":"Arb Geb Pathol Anat Inst Tuebingen"},{"key":"490_CR2","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1046\/j.1442-2050.2002.00237.x","volume":"15","author":"E Volpin","year":"2002","unstructured":"Volpin E, Sauvanet A, Couvelard A, Belghiti J. Primary malignant melanoma of the esophagus: a case report and review of the literature. Dis Esophagus. 2002;15:244\u20139.","journal-title":"Dis Esophagus"},{"key":"490_CR3","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1097\/PAP.0b013e318216b99b","volume":"18","author":"M Bisceglia","year":"2011","unstructured":"Bisceglia M, Perri F, Tucci A, Tardio M, Panniello G, Vita G, et al. Primary malignant melanoma of the esophagus: a clinicopathologic study of a case with comprehensive literature review. Adv Anat Pathol. 2011;18:235\u201352.","journal-title":"Adv Anat Pathol"},{"key":"490_CR4","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1007\/BF01606502","volume":"418","author":"K Yamazaki","year":"1991","unstructured":"Yamazaki K, Ohmori T, Kumagai Y, Makuuchi H, Eyden B. Ultrastructure of oesophageal melanocytosis. Virchows Arch A Pathol Anat Histopathol. 1991;418:515\u201322.","journal-title":"Virchows Arch A Pathol Anat Histopathol"},{"key":"490_CR5","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/BF02190531","volume":"417","author":"K Ohashi","year":"1990","unstructured":"Ohashi K, Kato Y, Kanno J, Kasuga T. Melanocytes and melanosis of the oesophagus in Japanese subjects\u2014analysis of factors effecting their increase. Virchows Arch A Pathol Anat Histopathol. 1990;417:137\u201343.","journal-title":"Virchows Arch A Pathol Anat Histopathol"},{"key":"490_CR6","doi-asserted-by":"crossref","first-page":"154","DOI":"10.4030\/jjcs1979.30.2_154","volume":"30","author":"T Maekawa","year":"2005","unstructured":"Maekawa T, Satoh K, Maekawa H, Wada R, Matsumoto M. A case of primary malignant melanoma arising in the esophagus. Nippon Gekakei Rengo Gakkai Zasshi. 2005;30:154\u20139.","journal-title":"Nippon Gekakei Rengo Gakkai Zasshi"},{"key":"490_CR7","first-page":"1475","volume":"84","author":"S Sabanathan","year":"1989","unstructured":"Sabanathan S, Eng J, Pradhan GN. Primary malignant melanoma of the esophagus. Am J Gastroenterol. 1989;84:1475\u201381.","journal-title":"Am J Gastroenterol"},{"key":"490_CR8","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/S0003-4975(10)61963-7","volume":"39","author":"G Chalkiadakis","year":"1985","unstructured":"Chalkiadakis G, Wihlm JM, Morand G, Weill-Bousson M, Witz JP. Primary malignant melanoma of the esophagus. Ann Thorac Surg. 1985;39:472\u20135.","journal-title":"Ann Thorac Surg"},{"key":"490_CR9","doi-asserted-by":"crossref","unstructured":"Japan Esophageal Society. Japanese Classification of Esophageal Cancer, tenth edition: part I. Esophagus. 2009;6:1\u201325.","DOI":"10.1007\/s10388-009-0169-0"},{"key":"490_CR10","first-page":"286","volume":"20","author":"K Taniyama","year":"1990","unstructured":"Taniyama K, Suzuki H, Sakuramachi S, Toyoda T, Matsuda M, Tahara E. Amelanotic malignant melanoma of the esophagus: case report and review of the literature. Jpn J Clin Oncol. 1990;20:286\u201395.","journal-title":"Jpn J Clin Oncol"},{"key":"490_CR11","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0003-4975(95)00084-4","volume":"60","author":"AW Joob","year":"1995","unstructured":"Joob AW, Haines GK 3rd, Kies MS, Shields TW. Primary malignant melanoma of the esophagus. Ann Thorac Surg. 1995;60:217\u201322.","journal-title":"Ann Thorac Surg"},{"key":"490_CR12","first-page":"1459","volume":"32","author":"N Kato","year":"1986","unstructured":"Kato N, Kamino K, Yamashita T, Umeyama K, Mitsuhashi T. Primary malignant melanoma of the esophagus. Gan No Rinsho. 1986;32:1459\u201365.","journal-title":"Gan No Rinsho"},{"key":"490_CR13","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1097\/00000478-198701000-00006","volume":"11","author":"DP DiCostanzo","year":"1987","unstructured":"DiCostanzo DP, Urmacher C. Primary malignant melanoma of the esophagus. Am J Surg Pathol. 1987;11:46\u201352.","journal-title":"Am J Surg Pathol"},{"key":"490_CR14","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1097\/00008390-200312000-00009","volume":"13","author":"CM Lohmann","year":"2003","unstructured":"Lohmann CM, Hwu WJ, Iversen K, Jungbluth AA, Busam KJ. Primary malignant melanoma of the oesophagus: a clinical and pathological study with emphasis on the immunophenotype of the tumours for melanocyte differentiation markers and cancer\/testis antigens. Melanoma Res. 2003;13:595\u2013601.","journal-title":"Melanoma Res"},{"key":"490_CR15","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1097\/CMR.0b013e3281c4a079","volume":"17","author":"B Li","year":"2007","unstructured":"Li B, Lei W, Shao K, Zhang C, Chen Z, Shi S, et al. Characteristics and prognosis of primary malignant melanoma of the esophagus. Melanoma Res. 2007;17:239\u201342.","journal-title":"Melanoma Res"},{"key":"490_CR16","first-page":"1491","volume":"41","author":"F Crippa","year":"2000","unstructured":"Crippa F, Leutner M, Belli F, Gallino F, Greco M, Pilotti S, et al. Which kinds of lymph node metastases can FDG PET detect? A clinical study in melanoma. J Nucl Med. 2000;41:1491\u20134.","journal-title":"J Nucl Med"},{"key":"490_CR17","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1055\/s-2007-1001373","volume":"30","author":"M Horowitz","year":"1998","unstructured":"Horowitz M, Nobrega MM. Primary anal melanoma associated with melanosis of the upper gastrointestinal tract. Endoscopy. 1998;30:662\u20135.","journal-title":"Endoscopy"},{"key":"490_CR18","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s004280000220","volume":"437","author":"A Walter","year":"2000","unstructured":"Walter A, van Rees BP, Heijnen BH, van Lanschot JJ, Offerhaus GJ. Atypical melanocytic proliferation associated with squamous cell carcinoma in situ of the esophagus. Virchows Arch. 2000;437:203\u20137.","journal-title":"Virchows Arch"},{"key":"490_CR19","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1055\/s-2007-1012807","volume":"22","author":"O Dumas","year":"1990","unstructured":"Dumas O, Barthelemy C, Billard F, Dumollard JM, Boucheron S, Calmard P, et al. Isolated melanosis of the esophagus: systematic endoscopic diagnosis. Endoscopy. 1990;22:94\u20135.","journal-title":"Endoscopy"},{"key":"490_CR20","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0016-5085(91)90576-7","volume":"100","author":"SS Sharma","year":"1991","unstructured":"Sharma SS, Venkateswaran S, Chacko A, Mathan M. Melanosis of the esophagus. An endoscopic, histochemical, and ultrastructural study. Gastroenterology. 1991;100:13\u20136.","journal-title":"Gastroenterology"},{"key":"490_CR21","doi-asserted-by":"crossref","first-page":"552","DOI":"10.5858\/2006-130-552-EMMFAR","volume":"130","author":"F Chang","year":"2006","unstructured":"Chang F, Deere H. Esophageal melanocytosis morphologic features and review of the literature. Arch Pathol Lab Med. 2006;130:552\u20137.","journal-title":"Arch Pathol Lab Med"},{"issue":"Pt 2","key":"490_CR22","first-page":"1","volume":"18","author":"SE Mills","year":"1983","unstructured":"Mills SE, Cooper PH. Malignant melanoma of the digestive system. Pathol Annu. 1983;18(Pt 2):1\u201326.","journal-title":"Pathol Annu"},{"key":"490_CR23","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1093\/jnci\/56.3.489","volume":"56","author":"J Scotto","year":"1976","unstructured":"Scotto J, Fraumeni JF Jr, Lee JA. Melanomas of the eye and other noncutaneous sites: epidemiologic aspects. J Natl Cancer Inst. 1976;56:489\u201391.","journal-title":"J Natl Cancer Inst"},{"key":"490_CR24","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1001\/archsurg.1964.01310240065013","volume":"88","author":"TK Dasgupta","year":"1964","unstructured":"Dasgupta TK, Brasfield RD. Metastatic melanoma of the gastrointestinal tract. Arch Surg. 1964;88:969\u201373.","journal-title":"Arch Surg"},{"key":"490_CR25","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.5858\/2008-132-1623-COPAMM","volume":"132","author":"AA Sanchez","year":"2008","unstructured":"Sanchez AA, Wu TT, Prieto VG, Rashid A, Hamilton SR, Wang H. Comparison of primary and metastatic malignant melanoma of the esophagus: clinicopathologic review of 10 cases. Arch Pathol Lab Med. 2008;132:1623\u20139.","journal-title":"Arch Pathol Lab Med"},{"key":"490_CR26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/1097-0142(195301)6:1<1::AID-CNCR2820060102>3.0.CO;2-C","volume":"6","author":"AC Allen","year":"1953","unstructured":"Allen AC, Spitz S. Malignant melanoma; a clinicopathological analysis of the criteria for diagnosis and prognosis. Cancer. 1953;6:1\u201345.","journal-title":"Cancer"},{"key":"490_CR27","doi-asserted-by":"crossref","unstructured":"Lerut T, Nafteux P, Moons J, Coosemans W, Decker G, De Leyn P, et al. Three-field lymphadenectomy for carcinoma of the esophagus and gastroesophageal junction in 174 R0 resections: impact on staging, disease-free survival, and outcome: a plea for adaptation of TNM classification in upper-half esophageal carcinoma. Ann Surg. 2004;240:962\u201372 (discussion 72\u20134).","DOI":"10.1097\/01.sla.0000145925.70409.d7"},{"key":"490_CR28","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/j.1443-1661.2009.00902.x","volume":"21","author":"H Miyatani","year":"2009","unstructured":"Miyatani H, Yoshida Y, Ushimaru S, Sagihara N, Yamada S. Slow growing flat-type primary malignant melanoma of the esophagus treated with cap-assisted EMR. Dig Endosc. 2009;21:255\u20137.","journal-title":"Dig Endosc"},{"key":"490_CR29","first-page":"73","volume":"3","author":"H Suzuki","year":"1980","unstructured":"Suzuki H, Nagayo T. Primary tumors of the esophagus other than squamous cell carcinoma\u2014histologic classification and statistics in the surgical and autopsied materials in Japan. Int Adv Surg Oncol. 1980;3:73\u2013109.","journal-title":"Int Adv Surg Oncol"},{"key":"490_CR30","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1136\/thx.46.5.397","volume":"46","author":"FC Hamdy","year":"1991","unstructured":"Hamdy FC, Smith JH, Kennedy A, Thorpe JA. Long survival after excision of a primary malignant melanoma of the oesophagus. Thorax. 1991;46:397\u20138.","journal-title":"Thorax"},{"key":"490_CR31","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/S0003-3944(01)00553-3","volume":"126","author":"A Khoury-Helou","year":"2001","unstructured":"Khoury-Helou A, Lozac\u2019h C, Vandenbrouke F, Lozac\u2019h P. Primary malignant melanoma of the esophagus. Ann Chir. 2001;126:557\u201360.","journal-title":"Ann Chir"},{"key":"490_CR32","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1023\/B:DDAS.0000043379.60295.cb","volume":"49","author":"H Uetsuka","year":"2004","unstructured":"Uetsuka H, Naomoto Y, Fujiwara T, Shirakawa Y, Noguchi H, Yamatsuji T, et al. Primary malignant melanoma of the esophagus: long-term survival following pre- and postoperative adjuvant hormone\/chemotherapy. Dig Dis Sci. 2004;49:1646\u201351.","journal-title":"Dig Dis Sci"},{"key":"490_CR33","first-page":"86","volume":"41","author":"OW Suehs","year":"1961","unstructured":"Suehs OW. Malignant melanoma of the esophagus. Trans Annu Meet Am Bronchoesophagol Assoc. 1961;41:86\u201393.","journal-title":"Trans Annu Meet Am Bronchoesophagol Assoc"},{"key":"490_CR34","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1365-2559.1992.tb00923.x","volume":"20","author":"JI Mik De","year":"1992","unstructured":"De Mik JI, Kooijman CD, Hoekstra JB, Tytgat GN. Primary malignant melanoma of the oesophagus. Histopathology. 1992;20:77\u20139.","journal-title":"Histopathology"},{"key":"490_CR35","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1097\/JTO.0b013e3181a8ca9f","volume":"4","author":"V Gupta","year":"2009","unstructured":"Gupta V, Kochhar R, Sinha SK, Das A. Primary malignant melanoma of the esophagus: long-term survival after radical resection. J Thorac Oncol. 2009;4:1180\u20132.","journal-title":"J Thorac Oncol"},{"key":"490_CR36","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1007\/s11605-007-0417-3","volume":"12","author":"MC Cheung","year":"2008","unstructured":"Cheung MC, Perez EA, Molina MA, Jin X, Gutierrez JC, Franceschi D, et al. Defining the role of surgery for primary gastrointestinal tract melanoma. J Gastrointest Surg. 2008;12:731\u20138.","journal-title":"J Gastrointest Surg"},{"key":"490_CR37","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1097\/00000637-199201000-00017","volume":"28","author":"HI Saba","year":"1992","unstructured":"Saba HI, Cruse CW, Wells KE, Klein CJ, Reintgen DS. Treatment of stage IV malignant melanoma with dacarbazine, carmustine, cisplatin, and tamoxifen regimens: a University of South Florida and H. Lee Moffitt Melanoma Center Study. Ann Plast Surg. 1992;28:65\u20139.","journal-title":"Ann Plast Surg"},{"key":"490_CR38","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1002\/ijc.2910500410","volume":"50","author":"EF McClay","year":"1992","unstructured":"McClay EF, Mastrangelo MJ, Berd D, Bellet RE. Effective combination chemo\/hormonal therapy for malignant melanoma: experience with three consecutive trials. Int J Cancer. 1992;50:553\u20136.","journal-title":"Int J Cancer"},{"key":"490_CR39","first-page":"1403","volume":"68","author":"SA Del Prete","year":"1984","unstructured":"Del Prete SA, Maurer LH, O\u2019Donnell J, Forcier RJ, LeMarbre P. Combination chemotherapy with cisplatin, carmustine, dacarbazine, and tamoxifen in metastatic melanoma. Cancer Treat Rep. 1984;68:1403\u20135.","journal-title":"Cancer Treat Rep"},{"key":"490_CR40","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1517\/14656566.4.12.2205","volume":"4","author":"MB Lens","year":"2003","unstructured":"Lens MB, Eisen TG. Systemic chemotherapy in the treatment of malignant melanoma. Expert Opin Pharmacother. 2003;4:2205\u201311.","journal-title":"Expert Opin Pharmacother"},{"key":"490_CR41","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.1200\/JCO.2000.18.12.2444","volume":"18","author":"JM Kirkwood","year":"2000","unstructured":"Kirkwood JM, Ibrahim JG, Sondak VK, Richards J, Flaherty LE, Ernstoff MS, et al. High- and low-dose interferon alfa-2b in high-risk melanoma: first analysis of intergroup trial E1690\/S9111\/C9190. J Clin Oncol. 2000;18:2444\u201358.","journal-title":"J Clin Oncol"},{"key":"490_CR42","doi-asserted-by":"crossref","unstructured":"Kyte JA, Gaudernack G, Dueland S, Trachsel S, Julsrud L, Aamdal S. Telomerase peptide vaccination combined with temozolomide: a clinical trial in stage IV melanoma patients. Clin Cancer Res. 2011;17:4568\u201380.","DOI":"10.1158\/1078-0432.CCR-11-0184"},{"key":"490_CR43","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1002\/cncr.25766","volume":"117","author":"HM Kluger","year":"2011","unstructured":"Kluger HM, Dudek AZ, McCann C, Ritacco J, Southard N, Jilaveanu LB, et al. A phase 2 trial of dasatinib in advanced melanoma. Cancer. 2011;117:2202\u20138.","journal-title":"Cancer"},{"key":"490_CR44","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1056\/NEJMoa1104621","volume":"364","author":"C Robert","year":"2011","unstructured":"Robert C, Thomas L, Bondarenko I, O\u2019Day S, Weber J, Garbe C, et al. Ipilimumab plus dacarbazine for previously untreated metastatic melanoma. N Engl J Med. 2011;364:2517\u201326.","journal-title":"N Engl J Med"},{"key":"490_CR45","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1097\/CJI.0b013e3181e032e8","volume":"33","author":"DT Alexandrescu","year":"2010","unstructured":"Alexandrescu DT, Ichim TE, Riordan NH, Marincola FM, Di Nardo A, Kabigting FD, et al. Immunotherapy for melanoma: current status and perspectives. J Immunother. 2010;33:570\u201390.","journal-title":"J Immunother"},{"key":"490_CR46","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1002\/cncr.25659","volume":"117","author":"LA Kottschade","year":"2011","unstructured":"Kottschade LA, Suman VJ, Amatruda T 3rd, McWilliams RR, Mattar BI, Nikcevich DA, et al. A phase II trial of nab-paclitaxel (ABI-007) and carboplatin in patients with unresectable stage IV melanoma: a North Central Cancer Treatment Group Study, N057E(1). Cancer. 2011;117:1704\u201310.","journal-title":"Cancer."},{"key":"490_CR47","doi-asserted-by":"crossref","unstructured":"Kirkwood JM, Gonzalez R, Reintgen D, Clingan PR, McWilliams RR, de Alwis DP, et al. A phase 2 study of tasisulam sodium (LY573636 sodium) as second-line treatment for patients with unresectable or metastatic melanoma. Cancer. 2011.","DOI":"10.1002\/cncr.26068"}],"container-title":["Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-011-0490-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00535-011-0490-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-011-0490-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,13]],"date-time":"2021-12-13T20:22:30Z","timestamp":1639426950000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00535-011-0490-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11,3]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["490"],"URL":"https:\/\/doi.org\/10.1007\/s00535-011-0490-y","relation":{},"ISSN":["0944-1174","1435-5922"],"issn-type":[{"value":"0944-1174","type":"print"},{"value":"1435-5922","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,11,3]]}}}